Information  X 
Enter a valid email address

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

By BFN News | 08:40 AM | Friday 31 January, 2020


UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t